Clopidogrel-Induced Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome After Coronary Artery Stenting

The antiplatelet drug clopidogrel has largely replaced ticlopidine, due to an association between ticlopidine and thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP-HUS). Clopidogrel at first was thought to be void of this potentially fatal adverse effect, but recent case reports hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Manor, Shawn M, Guillory, Gregory S, Jain, Suresh P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2004
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886298/
https://www.ncbi.nlm.nih.gov/pubmed/15162901
http://dx.doi.org/10.1592/phco.24.6.664.34732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886298/
https://www.ncbi.nlm.nih.gov/pubmed/15162901
http://dx.doi.org/10.1592/phco.24.6.664.34732

Ejemplares similares